M 
Mettler-Toledo International MTD · USD
Health Care · Life Sciences Tools & Services · US listing · 🇺🇸 United States
S&P 500
1,762.28
+2.33%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$4.03bn
FY2016FY2025
Net income
$869.2m
FY2016FY2025
Free cash flow
$848.6m
FY2016FY2025
Shareholders' equity
−$23.6m
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.03bn | $3.87bn | $3.79bn | $3.92bn | $3.72bn | $3.09bn | $3.01bn | $2.94bn | $2.73bn | $2.51bn |
| Gross profit | $2.32bn | $2.25bn | $2.24bn | $2.24bn | $2.11bn | $1.74bn | $1.69bn | $1.64bn | $1.53bn | $1.39bn |
| Research and development | $199.4m | $189.4m | $185.3m | $177.1m | $169.8m | $140.1m | $143.9m | $141.1m | $129.3m | $120.0m |
| Operating income | $1.12bn | $1.13bn | $1.15bn | $1.13bn | $994.7m | $784.0m | $728.4m | $683.0m | $609.9m | $540.2m |
| Net income | $869.2m | $863.1m | $788.8m | $872.5m | $769.0m | $602.7m | $561.1m | $512.6m | $376.0m | $384.4m |
| Diluted earnings per share | 42.65 | 40.91 | 36.37 | 38.94 | 33.12 | 25.15 | 22.81 | 20.11 | 14.33 | 14.43 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $3.71bn | $3.24bn | $3.36bn | $3.49bn | $3.33bn | $2.81bn | $2.79bn | $2.62bn | $2.55bn | $2.17bn |
| Cash and short-term investments | $66.9m | $59.4m | $69.8m | $96.0m | $98.6m | $94.3m | $207.8m | $178.1m | $148.7m | $158.7m |
| Total liabilities | $3.74bn | $3.37bn | $3.51bn | $3.47bn | $3.16bn | $2.53bn | $2.37bn | $2.03bn | $2.00bn | $1.73bn |
| Debt | $2.15bn | $2.01bn | $2.08bn | $2.01bn | $1.68bn | $1.33bn | $1.29bn | $1.03bn | $979.8m | $894.0m |
| Shareholders' equity | −$23.6m | −$126.9m | −$149.9m | $24.8m | $171.4m | $282.7m | $420.8m | $590.1m | $547.3m | $434.9m |
| Shares outstanding | 20m | 21m | 22m | 22m | 23m | 24m | 25m | 25m | 26m | 27m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $955.8m | $968.3m | $965.9m | $859.1m | $908.8m | $724.7m | $603.5m | $565.0m | $516.3m | $443.1m |
| Capital spending | −$107.1m | −$103.9m | −$105.3m | −$121.2m | −$107.6m | −$92.5m | −$97.3m | −$142.7m | −$127.4m | −$124.0m |
| Free cash flow | $848.6m | $864.4m | $860.6m | $737.8m | $801.2m | $632.2m | $506.1m | $422.3m | $388.9m | $319.1m |
| Dividends paid | — | — | −$19.2m | — | −$20.5m | −$26.7m | −$47.6m | — | — | — |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.03bn | $947.1m | $1.13bn | $1.03bn | $983.2m | $883.7m | $1.05bn | $954.5m |
| Gross profit | $650.2m | $555.8m | $655.8m | $589.4m | $562.3m | $508.7m | $621.1m | $554.2m |
| Operating income | $306.6m | $246.2m | $343.3m | $289.9m | $265.7m | $219.5m | $333.7m | $278.3m |
| Net income | $232.9m | $169.5m | $285.8m | $217.5m | $202.3m | $163.6m | $252.3m | $211.5m |
| Diluted earnings per share | 11.55 | 8.40 | 14.02 | 10.67 | 9.93 | 8.03 | 11.96 | 10.02 |
| Cash from operations | $310.0m | $139.0m | $225.0m | $299.0m | $236.0m | $194.0m | $266.0m | $254.0m |
| Capital spending | −$27.0m | −$17.0m | −$41.0m | −$24.0m | −$23.0m | −$17.0m | −$41.0m | −$21.0m |
| Free cash flow | $283.0m | $122.0m | $184.0m | $275.0m | $213.0m | $177.0m | $225.0m | $233.0m |
| Total assets | $3.67bn | $3.67bn | $3.71bn | $3.52bn | $3.40bn | $3.23bn | $3.24bn | $3.32bn |
| Cash and short-term investments | $51.4m | $60.6m | $66.9m | $69.1m | $61.8m | $64.3m | $59.4m | $71.6m |
| Debt | $2.11bn | $2.23bn | $2.19bn | $2.21bn | $2.18bn | $2.07bn | $2.04bn | $2.08bn |
| Shareholders' equity | $12.8m | −$41.9m | −$23.6m | −$249.2m | −$258.8m | −$182.0m | −$126.9m | −$154.4m |
Financial ratios
Data as of 23 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 57.5% | 58.2% | 59.2% | 57.2% | 56.7% | 56.5% |
| Operating margin | 27.8% | 29.1% | 30.4% | 28.7% | 26.8% | 25.4% |
| Net margin | 21.6% | 22.3% | 20.8% | 22.3% | 20.7% | 19.5% |
| Return on equity | -3677.4% | -680.2% | -526.1% | 3519.1% | 448.6% | 213.2% |
| Return on assets | 23.4% | 26.6% | 23.5% | 25.0% | 23.1% | 21.4% |
| Free cash flow yield | 3.5% | 3.4% | 3.3% | 2.9% | 2.9% | 2.3% |
| Revenue growth | 4.0% | 2.2% | -3.4% | 5.4% | 20.5% | 2.5% |
| Earnings growth | 0.7% | 9.4% | -9.6% | 13.5% | 27.6% | 7.4% |
| Current ratio | 1.14x | 1.02x | 1.04x | 1.20x | 1.11x | 1.26x |
| Debt to equity | -92.54x | -16.11x | -14.07x | 82.43x | 9.99x | 4.72x |
| Equity ratio | -0.6% | -3.9% | -4.5% | 0.7% | 5.2% | 10.0% |
| Interest coverage | 16.32x | 15.10x | 14.89x | 20.33x | 23.00x | 20.30x |
| R&D as a share of sales | 5.0% | 4.9% | 4.9% | 4.5% | 4.6% | 4.5% |
| Buybacks as a share of market value | 3.1% | 2.7% | 3.2% | 3.5% | 3.1% | 2.6% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 0.9% | 5.5% | 5.3% |
| Operating income | -0.2% | 7.4% | 8.1% |
| Net income | -0.1% | 7.6% | 9.4% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 57.8% | 58.0% | 57.6% | 57.0% |
| Operating margin | 28.4% | 29.0% | 28.1% | 26.1% |
| Net margin | 21.9% | 21.7% | 21.3% | 19.3% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 32.7 | 29.9 | 33.4 | 37.1 | 51.3 | 45.3 | 34.8 | 28.1 | 43.2 | 29.0 |
| Price to sales | 7.1 | 6.7 | 6.9 | 8.3 | 10.6 | 8.8 | 6.5 | 4.9 | 6.0 | 4.4 |
Market value over time
31 Oct 2016 to 22 Sept 2026, in USD
$10.87bn$30.06bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 14% | 1% | -14% | -10% | 37% | 43% | 43% | -12% | 47% | 29% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.